What does Pluto Bio do?
Pluto Bio offers an AI-powered platform for computational biology that integrates data management, analysis, and visualization for multi-omics. Designed specifically for pharma companies, the platform helps scientists analyze large-scale biological data without coding, facilitating target discovery and translational medicine.
How much did they raise?
The company raised $3.6M in funding in a round led by Kickstart, with participation from existing investor Silverton Partners and angel investors.
What are their plans for the money?
With the new funds, Pluto Bio intends to accelerate growth and scale the adoption of its platform among global pharma companies, potentially transforming research and development in the life sciences industry.
What have they achieved so far?
The platform is already being utilized by mid-market and enterprise clients across North America and Europe, supporting teams in discovery biology, translational research, and computational analysis.
